Radu O. Minea, MD

Title(s)Assistant Professor of Research Neurological Surgery
SchoolKeck School of Medicine of Usc
AddressHMR 2011 Zonal Avenue 414
Health Sciences Campus
Los Angeles CA 90089-0110
Phone+1 323 442 5680
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Potent Therapeutic Activity of NEO212 in Preclinical Models of Human and Canine Leukaemia and Lymphoma. Vet Comp Oncol. 2025 May 16. Chen TC, Swenson S, Thein TZ, Minea RO, Schönthal AH. PMID: 40377133.
      View in: PubMed   Mentions:    Fields:    
    2. NEO212, temozolomide conjugated to NEO100, exerts superior therapeutic activity over temozolomide in preclinical chemoradiation models of glioblastoma. Neurooncol Adv. 2024 Jan-Dec; 6(1):vdae095. Minea RO, Thein TZ, Yang Z, Campan M, Ward PM, Schönthal AH, Chen TC. PMID: 39022643; PMCID: PMC11252566.
      View in: PubMed   Mentions:
    3. Activation of Epstein-Barr Virus' Lytic Cycle in Nasopharyngeal Carcinoma Cells by NEO212, a Conjugate of Perillyl Alcohol and Temozolomide. Cancers (Basel). 2024 Feb 26; 16(5). Hartman-Houstman H, Swenson S, Minea RO, Sinha UK, Chiang MF, Chen TC, Schönthal AH. PMID: 38473298; PMCID: PMC10931041.
      View in: PubMed   Mentions: 2  
    4. Inhibition of autophagy and induction of glioblastoma cell death by NEO214, a perillyl alcohol-rolipram conjugate. Autophagy. 2023 12; 19(12):3169-3188. Ou M, Cho HY, Fu J, Thein TZ, Wang W, Swenson SD, Minea RO, Stathopoulos A, Schönthal AH, Hofman FM, Tang L, Chen TC. PMID: 37545052; PMCID: PMC10621246.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    5. Enhanced brain entry of checkpoint-inhibitory therapeutic antibodies facilitated by intraarterial NEO100 in mouse models of brain-localized malignancies. J Neurosurg. 2023 09 01; 139(3):822-830. Wang W, He H, Zeng S, Cho HY, Minea RO, Swenson SD, Zheng L, Epstein AL, Stathopoulos A, Chen L, Schönthal AH, Chen TC. PMID: 36738464.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    6. NEO212, a Perillyl Alcohol-Temozolomide Conjugate, Triggers Macrophage Differentiation of Acute Myeloid Leukemia Cells and Blocks Their Tumorigenicity. Cancers (Basel). 2022 Dec 09; 14(24). Chen TC, Minea RO, Swenson S, Yang Z, Thein TZ, Schönthal AH. PMID: 36551551; PMCID: PMC9776529.
      View in: PubMed   Mentions: 6  
    7. Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid Leukemia. Cancers (Basel). 2021 Jul 06; 13(14). Schönthal AH, Swenson S, Minea RO, Kim HN, Cho H, Mohseni N, Kim YM, Chen TC. PMID: 34298603; PMCID: PMC8305595.
      View in: PubMed   Mentions: 2  
    8. Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas. PLoS One. 2020; 15(9):e0238238. Minea RO, Duc TC, Swenson SD, Cho HY, Huang M, Hartman H, Hofman FM, Schönthal AH, Chen TC. PMID: 32881880; PMCID: PMC7470340.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    9. Cytotoxic impact of a perillyl alcohol-temozolomide conjugate, NEO212, on cutaneous T-cell lymphoma in vitro. Ther Adv Med Oncol. 2019; 11:1758835919891567. Silva-Hirschberg C, Hartman H, Stack S, Swenson S, Minea RO, Davitz MA, Chen TC, Schönthal AH. PMID: 31839810; PMCID: PMC6900611.
      View in: PubMed   Mentions: 7  
    10. A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice. Molecules. 2018 Nov 08; 23(11). Swenson S, Minea RO, Tuan CD, Thein TZ, Chen TC, Markland FS. PMID: 30413113; PMCID: PMC6278533.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    11. Rare Stochastic Expression of O6-Methylguanine- DNA Methyltransferase (MGMT) in MGMT-Negative Melanoma Cells Determines Immediate Emergence of Drug-Resistant Populations upon Treatment with Temozolomide In Vitro and In Vivo. Cancers (Basel). 2018 Sep 28; 10(10). Chen TC, Chan N, Minea RO, Hartman H, Hofman FM, Schönthal AH. PMID: 30274152; PMCID: PMC6209933.
      View in: PubMed   Mentions: 3  
    12. Multimeric disintegrin protein polymer fusions that target tumor vasculature. Biomacromolecules. 2014 Jul 14; 15(7):2347-58. Janib SM, Gustafson JA, Minea RO, Swenson SD, Liu S, Pastuszka MK, Lock LL, Cui H, Markland FS, Conti PS, Li Z, MacKay JA. PMID: 24871936; PMCID: PMC4098058.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    13. Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential. Toxicon. 2012 Mar 15; 59(4):472-86. Minea R, Helchowski C, Rubino B, Brodmann K, Swenson S, Markland F. PMID: 21354198; PMCID: PMC3130806.
      View in: PubMed   Mentions: 10     Fields:    
    14. Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities. PLoS One. 2010 Jun 03; 5(6):e10929. Minea RO, Helchowski CM, Zidovetzki SJ, Costa FK, Swenson SD, Markland FS. PMID: 20532165; PMCID: PMC2880590.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    15. The use of pepsin in receptor internalization assays. Biochem Biophys Res Commun. 2009 Oct 16; 388(2):240-6. Helchowski CM, Minea RO, Swenson SD, Markland FS. PMID: 19665997.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    16. Development of a novel recombinant disintegrin, contortrostatin, as an effective anti-tumor and anti-angiogenic agent. Pathophysiol Haemost Thromb. 2005; 34(4-5):177-83. Minea R, Swenson S, Costa F, Chen TC, Markland FS. PMID: 16707923.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    17. Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression. Mol Cancer Ther. 2004 Apr; 3(4):499-511. Swenson S, Costa F, Minea R, Sherwin RP, Ernst W, Fujii G, Yang D, Markland FS. PMID: 15078994.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    Radu's Networks
    Concepts (85)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (7)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.